| Literature DB >> 35256801 |
Sakshi Jasra1,2, Orsi Giricz1, Rachel Zeig-Owens3,4,5, Kith Pradhan1, David G Goldfarb3,4, Angelica Barreto-Galvez6, Alexander J Silver7, Jiahao Chen1, Srabani Sahu1, Shanisha Gordon-Mitchell1, Gaurav S Choudhary1, Srinivas Aluri1, Tushar D Bhagat1, Aditi Shastri1, Cosmin A Bejan7, Shannon S Stockton7, Travis P Spaulding7, Victor Thiruthuvanathan1, Hiroki Goto1, Jeannine Gerhardt8, Syed Hissam Haider9, Arul Veerappan9, Matthias Bartenstein1, George Nwankwo1, Ola Landgren10, Michael D Weiden4,9, Jacqueline Lekostaj11, Ryan Bender11, Frederick Fletcher11, Lee Greenberger12, Benjamin L Ebert13,14, Ulrich Steidl1, Britta Will1, Anna Nolan15,16, Advaitha Madireddy17, Michael R Savona18, David J Prezant19,20, Amit Verma21.
Abstract
The terrorist attacks on the World Trade Center (WTC) created an unprecedented environmental exposure to aerosolized dust, gases and potential carcinogens. Clonal hematopoiesis (CH) is defined as the acquisition of somatic mutations in blood cells and is associated with smoking and exposure to genotoxic stimuli. Here we show that deep targeted sequencing of blood samples identified a significantly higher proportion of WTC-exposed first responders with CH (10%; 48 out of 481) when compared with non-WTC-exposed firefighters (6.7%; 17 out of 255; odds ratio, 3.14; 95% confidence interval, 1.64-6.03; P = 0.0006) after controlling for age, sex and race/ethnicity. The frequency of somatic mutations in WTC-exposed first responders showed an age-related increase and predominantly affected DNMT3A, TET2 and other CH-associated genes. Exposure of lymphoblastoid cells to WTC particulate matter led to dysregulation of DNA replication at common fragile sites in vitro. Moreover, mice treated with WTC particulate matter developed an increased burden of mutations in hematopoietic stem and progenitor cell compartments. In summary, the high burden of CH in WTC-exposed first responders provides a rationale for enhanced screening and preventative efforts in this population.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35256801 PMCID: PMC9394171 DOI: 10.1038/s41591-022-01708-3
Source DB: PubMed Journal: Nat Med ISSN: 1078-8956 Impact factor: 87.241